Literature DB >> 29796951

Liver transplantation due to cerebrotendinous xanthomatosis end-stage liver disease.

Cong-Huan Shen1, Zheng-Xin Wang2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29796951     DOI: 10.1007/s12519-018-0151-9

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


× No keyword cloud information.
  2 in total

1.  Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study.

Authors:  M Mondelli; F Sicurelli; C Scarpini; M T Dotti; A Federico
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

Review 2.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Authors:  Shuke Nie; Guiqin Chen; Xuebing Cao; Yunjian Zhang
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

  2 in total
  1 in total

Review 1.  The clinical and imaging features of cerebrotendinous xanthomatosis: A case report and review of the literature.

Authors:  Chi Ma; Yan-De Ren; Jia-Chen Wang; Cheng-Jian Wang; Ji-Ping Zhao; Tong Zhou; Hua-Wei Su
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.